Cognitive Health
BioAdaptives Launches MyndSystem Platform to Target Cognitive Performance and Recovery
BioAdaptives, Inc. launched MyndSystem, a dual-phase cognitive support platform with daytime and nighttime formulations, aiming to enhance focus, clarity, sleep quality, and neurological recovery, positioning it as a long-term growth driver.
Study Finds Exercise and Ibuprofen May Alleviate Chemo Brain in Cancer Patients
New research suggests that exercise and the common over-the-counter drug ibuprofen can help combat cognitive decline in cancer patients undergoing chemotherapy and radiation, a condition known as chemo brain.
BioAdaptives Launches MyndMed Cognitive-Support Supplement After Positive Testing
BioAdaptives Inc. announced the commercial launch of MyndMed, a dietary supplement for cognitive support, following successful testing and strong early demand, with production scaling and distribution expanding nationwide.
Jupiter Neurosciences Expands Brain Health Reach with Nugevia Supplement Line
Jupiter Neurosciences leverages its pharmaceutical expertise to launch Nugevia MND, a cognitive health supplement that addresses growing global demand for brain health solutions amid aging populations and represents a strategic bridge between clinical research and consumer wellness.
La Posada Book Club Demonstrates Cognitive and Social Benefits for Seniors During National Book Month
A thriving book club at La Posada retirement community shows how reading and social engagement provide significant cognitive and emotional benefits for older adults, supported by research from leading health organizations.
BioAdaptives Launches MyndMed Cognitive Supplement Following Positive Testing Results
BioAdaptives has commercially launched MyndMed, a cognitive-support dietary supplement designed to enhance memory and focus, representing the company's expansion into the growing brain health market with a product backed by positive user feedback and clinical research.
Jupiter Neurosciences Launches Consumer Longevity Line Nugevia Using Patented JOTROL Technology
Jupiter Neurosciences introduces Nugevia, a direct-to-consumer product line leveraging its clinically proven JOTROL formulation to address mitochondrial health, cognitive function, and skin benefits while generating revenue alongside pharmaceutical development.
BFCH Strengthens Portfolio with Acquisition of EVERMIND™ Beverage, Aiming for Cognitive Health Market Leadership
BitFrontier Capital Holdings, Inc. (BFCH) has signed a binding LOI to acquire EVERMIND™, a science-backed cognitive health beverage platform, marking a strategic move to bolster its balance sheet and position for future growth in the wellness sector.
Bone Science Unveils Advanced Brain Supplement for Youth Academic Performance
A new cognitive supplement targeting academic performance and stress management in children and adolescents marks a significant development in youth cognitive health support, potentially addressing growing concerns about academic pressure and mental wellness in young students.
Bone Science Launches Advanced Cellular Health and Brain Enhancement Supplements
Bone Science's introduction of Prime NMN and Prime Brain supplements marks a significant advancement in personalized healthcare, offering solutions for cellular regeneration and cognitive enhancement across different age groups.
AI-Powered ECG Analysis Shows Promise in Detecting Cognitive Decline
A new study reveals that artificial intelligence analysis of ECG data could potentially identify premature aging and cognitive decline, offering a novel approach to early detection of age-related cognitive issues using widely available medical technology.